 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- || ET0111 / Etern Biopharma
New P1 trial, Monotherapy, Metastases: FLIGHT: FGFR Inhibitor ET0111 Monotherapy in Patients With Advanced Solid Tumors (clinicaltrials.gov) - Aug 31, 2022
P1, N=37, Recruiting, Sponsor: Etern BioPharma (Shanghai) Co., Ltd